DexCom Inc (DXCM)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$61.50
Buy
$64.00
$-0.15 (-0.24%)
Prices updated at 03 Apr 2026, 00:44 EDT
| Prices minimum 15 mins delay
Prices in USD
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin R. Sayer, C.P.A.
CEO
Mr. Jacob S. Leach
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
11,100
Head office
6340 Sequence Drive
San Diego
United States
92121
Key personnel
Owner name | Salary |
|---|---|
Mr. Albert F. Osterloh, IV Independent Director | - |
Mr. Kevin R. Sayer, C.P.A. Executive Chairman of the Board | 1.16m |
Mr. Mark G. Foletta Lead Independent Director | - |
Mr. Steven R. Altman Independent Director | - |
Mr. Nicholas Augustinos Independent Director | - |
Ms. Bridgette P. Heller Independent Director | - |
Ms. Renee D. Gala Independent Director | - |
Mr. Jereme M. Sylvain Executive Vice President, Chief Financial Officer and Principal Accounting Officer | 0.61m |
Mr. Richard A. Collins Independent Director | - |
Mr. Jacob S. Leach Director, President and Chief Executive Officer | 0.68m |
Mr. Kyle Malady Independent Director | - |
Dr. Euan A. Ashley Independent Director | - |
Ms. Rimma Driscoll Independent Director | - |
Ms. Sadie M. Stern Executive Vice President and Chief Human Resources Officer | 0.54m |
Mr. Michael J. Brown Executive Vice President and Chief Legal Officer | 0.60m |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 49,074,378 |
| BlackRock Inc | 38,821,843 |
| State Street Corp | 16,855,113 |
| Vanguard | 16,647,666 |
| BlackRock Fund Advisors | 15,908,191 |
Director dealings
Date | Action |
|---|---|
| 14 Nov 2025 | - |
| 12 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 24 Oct 2025 | - |
| 05 Sep 2025 | - |
| 04 Sep 2025 | - |
| 02 Sep 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 28 Jul 2025 | - |
| 15 Jul 2025 | - |
| 15 Jul 2025 | - |
| 15 Jul 2025 | - |
| 26 Jun 2025 | - |
| 16 Jun 2025 | - |
| 16 Jun 2025 | - |
| 16 Jun 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
